{"transactions":[{"id":892825,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T01:52:16.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1161,"price":126.34,"value":146680.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."}],"balance_after":192083,"source":{"system":"sec-edgar","filing":"0001399546-26-000004","document":"wk-form4_1771552333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000004/wk-form4_1771552333.xml","form_type":"4"}},{"id":892824,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T01:52:16.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":2281,"price":124.6573,"value":284343.3013,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.3500 to $125.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":193244,"source":{"system":"sec-edgar","filing":"0001399546-26-000004","document":"wk-form4_1771552333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000004/wk-form4_1771552333.xml","form_type":"4"}},{"id":892823,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T01:52:16.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":3556,"price":123.9286,"value":440690.1016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.3300 to $124.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":195525,"source":{"system":"sec-edgar","filing":"0001399546-26-000004","document":"wk-form4_1771552333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000004/wk-form4_1771552333.xml","form_type":"4"}},{"id":892822,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T01:52:16.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":4250,"price":122.8438,"value":522086.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.3200 to $123.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":199081,"source":{"system":"sec-edgar","filing":"0001399546-26-000004","document":"wk-form4_1771552333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000004/wk-form4_1771552333.xml","form_type":"4"}},{"id":892821,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T01:52:16.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":753,"price":122.1569,"value":91984.1457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.1000 to $122.2800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":203331,"source":{"system":"sec-edgar","filing":"0001399546-26-000004","document":"wk-form4_1771552333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000004/wk-form4_1771552333.xml","form_type":"4"}},{"id":911497,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T23:52:38.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":11787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent an award of restricted stock units (\"RSUs\") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":204084,"source":{"system":"sec-edgar","filing":"0001399546-26-000002","document":"wk-form4_1770767556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954626000002/wk-form4_1770767556.xml","form_type":"4"}},{"id":993543,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:21:56.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":3238,"price":143.5155,"value":464703.189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.0000 to $143.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":192297,"source":{"system":"sec-edgar","filing":"0001399546-25-000007","document":"wk-form4_1763587313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954625000007/wk-form4_1763587313.xml","form_type":"4"}},{"id":993542,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:21:56.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":4459,"price":144.5342,"value":644477.9978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.0000 to $144.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":195535,"source":{"system":"sec-edgar","filing":"0001399546-25-000007","document":"wk-form4_1763587313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954625000007/wk-form4_1763587313.xml","form_type":"4"}},{"id":993541,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:21:56.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":2609,"price":145.6908,"value":380107.2972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.0000 to $145.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":199994,"source":{"system":"sec-edgar","filing":"0001399546-25-000007","document":"wk-form4_1763587313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954625000007/wk-form4_1763587313.xml","form_type":"4"}},{"id":993540,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:21:56.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":1124,"price":146.4152,"value":164570.6848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.0000 to $146.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":202603,"source":{"system":"sec-edgar","filing":"0001399546-25-000007","document":"wk-form4_1763587313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954625000007/wk-form4_1763587313.xml","form_type":"4"}},{"id":1041292,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:15:24.000Z","date":"2025-09-11","kind":"gift","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":450281,"source":{"system":"sec-edgar","filing":"0001736297-25-000132","document":"wk-form4_1757708115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000132/wk-form4_1757708115.xml","form_type":"4"}},{"id":1060045,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T00:27:02.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":true,"shares":55785,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On August 19, 2025, the Reporting Person transferred 55,785 shares of Issuer Common Stock to Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\") for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are owned directly by the Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":457281,"source":{"system":"sec-edgar","filing":"0001736297-25-000114","document":"wk-form4_1755736017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000114/wk-form4_1755736017.xml","form_type":"4"}},{"id":1060044,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T00:27:02.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":false,"shares":55785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On August 19, 2025, the Reporting Person transferred 55,785 shares of Issuer Common Stock to Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\") for no consideration."}],"balance_after":203727,"source":{"system":"sec-edgar","filing":"0001736297-25-000114","document":"wk-form4_1755736017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000114/wk-form4_1755736017.xml","form_type":"4"}},{"id":1060043,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T00:27:02.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":9193,"price":183.1692,"value":1683874.4556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.4400  to $182.8700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":259512,"source":{"system":"sec-edgar","filing":"0001736297-25-000114","document":"wk-form4_1755736017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000114/wk-form4_1755736017.xml","form_type":"4"}},{"id":1060042,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T00:27:02.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":9668,"price":183.8343,"value":1777310.0124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.4400  to $183.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":268705,"source":{"system":"sec-edgar","filing":"0001736297-25-000114","document":"wk-form4_1755736017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000114/wk-form4_1755736017.xml","form_type":"4"}},{"id":1060041,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-08","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":501496,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1060040,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-07","kind":"gift","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a bona fide gift of shares to a non-affiliated entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":511496,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1060039,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":34125,"price":173.8234,"value":5931723.525,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":518996,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1060038,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":15141,"price":171.4778,"value":2596345.3698,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":553121,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1060037,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":7550,"price":170.3396,"value":1286063.98,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":568262,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1060036,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:02:36.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":43184,"price":169.608,"value":7324351.872,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":575812,"source":{"system":"sec-edgar","filing":"0001736297-25-000108","document":"wk-form4a_1755723751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000108/wk-form4a_1755723751.xml","form_type":"4/A","original_submission_date":"2025-08-11"}},{"id":1066170,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-14T20:31:51.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":1065,"price":192.5156,"value":205029.114,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.5000 to $192.5500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":401496,"source":{"system":"sec-edgar","filing":"0001736297-25-000106","document":"wk-form4_1755203476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000106/wk-form4_1755203476.xml","form_type":"4"}},{"id":1066169,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-14T20:31:51.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":32374,"price":191.9162,"value":6213095.0588,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $191.5000 to $192.4900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":402561,"source":{"system":"sec-edgar","filing":"0001736297-25-000106","document":"wk-form4_1755203476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000106/wk-form4_1755203476.xml","form_type":"4"}},{"id":1066168,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-14T20:31:51.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":66561,"price":190.8154,"value":12700863.8394,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.5000 to $191.4950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":434935,"source":{"system":"sec-edgar","filing":"0001736297-25-000106","document":"wk-form4_1755203476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000106/wk-form4_1755203476.xml","form_type":"4"}},{"id":1069903,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-08","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":501496,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069902,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"gift","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GlobalStar DAF"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a bona fide gift of shares to GlobalStar DAF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are directly owned by the GlobalStar DAF, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069901,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"gift","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a bona fide gift of shares to GlobalStar DAF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":511496,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069900,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":34125,"price":173.8234,"value":5931723.525,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":518996,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069899,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":15141,"price":171.4778,"value":2596345.3698,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":553121,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069898,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":7550,"price":170.3396,"value":1286063.98,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":568262,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1069897,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-11T21:10:04.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":43184,"price":169.608,"value":7324351.872,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":575812,"source":{"system":"sec-edgar","filing":"0001736297-25-000102","document":"wk-form4_1754946599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000102/wk-form4_1754946599.xml","form_type":"4"}},{"id":1079655,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-30T01:31:14.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":43238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent an award of restricted stock units (\"RSUs\") granted on July 24, 2025 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on August 15, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":278373,"source":{"system":"sec-edgar","filing":"0001736297-25-000093","document":"wk-form4_1753839069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000093/wk-form4_1753839069.xml","form_type":"4"}},{"id":1124392,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":7100,"price":94.328,"value":669728.8,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.0400 to $94.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":618996,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124391,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":3968,"price":92.959,"value":368861.312,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.5400 to $93.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":626096,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124390,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":15492,"price":92.0366,"value":1425831.0072,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.5200 to $92.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":630064,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124389,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":204954,"price":90.7509,"value":18599759.9586,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.5200 to $91.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":645556,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124388,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":156288,"price":90.0648,"value":14076047.4624,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.5200 to $90.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":850510,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124387,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":92200,"price":89.0485,"value":8210271.7,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.5200 to $89.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1006798,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1124386,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:40:28.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":19998,"price":88.1442,"value":1762707.7116,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.5200 to $88.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1098998,"source":{"system":"sec-edgar","filing":"0001628280-25-029091","document":"wk-form4_1748983198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000162828025029091/wk-form4_1748983198.xml","form_type":"4"}},{"id":1140121,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T01:13:12.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":90.3343,"value":359440.1797,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock\nunits previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.2400 to $90.4200, inclusive. The Reporting Person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate\nprice within the range set forth in this footnote."}],"balance_after":235135,"source":{"system":"sec-edgar","filing":"0001736297-25-000040","document":"wk-form4_1747789985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000040/wk-form4_1747789985.xml","form_type":"4"}},{"id":1140120,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T01:13:12.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":4247,"price":90.6726,"value":385086.5322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock\nunits previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.4250 to $91.4200, inclusive. The Reporting Person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth in this footnote."}],"balance_after":239114,"source":{"system":"sec-edgar","filing":"0001736297-25-000040","document":"wk-form4_1747789985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000040/wk-form4_1747789985.xml","form_type":"4"}},{"id":1140119,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T01:13:12.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":881,"price":92.155,"value":81188.555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock\nunits previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.7300 to $92.5550, inclusive. The Reporting Person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth in this footnote."}],"balance_after":243361,"source":{"system":"sec-edgar","filing":"0001736297-25-000040","document":"wk-form4_1747789985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000040/wk-form4_1747789985.xml","form_type":"4"}},{"id":1238050,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:34:40.000Z","date":"2025-02-27","kind":"gift","planned":false,"acquired":false,"shares":125800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a bona fide gift of shares to a non-affiliated entity."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1118996,"source":{"system":"sec-edgar","filing":"0001736297-25-000017","document":"wk-form4_1740785673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000017/wk-form4_1740785673.xml","form_type":"4"}},{"id":1238049,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:34:40.000Z","date":"2025-02-26","kind":"sale","planned":false,"acquired":false,"shares":125800,"price":82.5349,"value":10382890.42,"ownership":{"direct":false,"nature":"By CRUT Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.5000 to $82.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the CRUT Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001736297-25-000017","document":"wk-form4_1740785673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000017/wk-form4_1740785673.xml","form_type":"4"}},{"id":1238048,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:34:40.000Z","date":"2025-02-26","kind":"gift","planned":false,"acquired":true,"shares":125800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CRUT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to Michael T Tate and Jeanne Larue Tate as Trustees of the GlobalStar 2025 CRUT (the \"CRUT Trust\"), a charitable remainder unitrust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the CRUT Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":125800,"source":{"system":"sec-edgar","filing":"0001736297-25-000017","document":"wk-form4_1740785673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000017/wk-form4_1740785673.xml","form_type":"4"}},{"id":1238047,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:34:40.000Z","date":"2025-02-26","kind":"gift","planned":false,"acquired":false,"shares":125800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to Michael T Tate and Jeanne Larue Tate as Trustees of the GlobalStar 2025 CRUT (the \"CRUT Trust\"), a charitable remainder unitrust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1244796,"source":{"system":"sec-edgar","filing":"0001736297-25-000017","document":"wk-form4_1740785673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000017/wk-form4_1740785673.xml","form_type":"4"}},{"id":1255248,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-20T23:51:40.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":34474,"price":92.0702,"value":3174028.0748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.8700 to $92.6700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":244242,"source":{"system":"sec-edgar","filing":"0001736297-25-000009","document":"wk-form4_1740095492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629725000009/wk-form4_1740095492.xml","form_type":"4"}},{"id":1332004,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-13T22:08:08.000Z","date":"2024-12-11","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1370596,"source":{"system":"sec-edgar","filing":"0001736297-24-000068","document":"wk-form4_1734127681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000068/wk-form4_1734127681.xml","form_type":"4"}},{"id":1332003,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-13T22:08:08.000Z","date":"2024-12-11","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1380596,"source":{"system":"sec-edgar","filing":"0001736297-24-000068","document":"wk-form4_1734127681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000068/wk-form4_1734127681.xml","form_type":"4"}},{"id":1332002,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-13T22:08:08.000Z","date":"2024-12-11","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of shares to a non-affiliated person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1390596,"source":{"system":"sec-edgar","filing":"0001736297-24-000068","document":"wk-form4_1734127681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000068/wk-form4_1734127681.xml","form_type":"4"}},{"id":1340200,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":683,"price":120.5836,"value":82358.5988,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.1800 to $121.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1412888,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1340199,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":4353,"price":119.6697,"value":520922.2041,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.1800 to $120.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1413571,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1340198,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":2602,"price":118.4388,"value":308177.7576,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.1500 to $119.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1417924,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1340197,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":2840,"price":117.6837,"value":334221.708,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.1400 to $118.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1420526,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1340196,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":116.6616,"value":221657.04,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.0900 to $117.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1423366,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1340195,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:31:30.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":3622,"price":115.4431,"value":418134.9082,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.0900 to $116.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1425266,"source":{"system":"sec-edgar","filing":"0001736297-24-000067","document":"wk-form4_1733520683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000067/wk-form4_1733520683.xml","form_type":"4"}},{"id":1342613,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1599,"price":117.1,"value":187242.9,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.0500 to $117.1700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1428888,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342612,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":23222,"price":116.4583,"value":2704394.6426,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.0500 to $117.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1430487,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342611,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":25978,"price":115.7146,"value":3006033.8788,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.0500 to $116.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1453709,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342610,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":19804,"price":114.5382,"value":2268314.5128,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $114.0500 to $115.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1479687,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342609,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":18489,"price":113.5427,"value":2099290.9803,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.0300 to $114.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1499491,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342608,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":27905,"price":112.5336,"value":3140250.108,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.0300 to $113.0200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1517980,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342607,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":19793,"price":111.3158,"value":2203273.6294,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.9700 to $111.9500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1545885,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342606,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":21670,"price":110.5248,"value":2395072.416,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.9700 to $110.9650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1565678,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342605,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":4575,"price":109.5832,"value":501343.14,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.9500 to $109.9200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1587348,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342604,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1180,"price":108.1583,"value":127626.794,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.8600 to $108.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1591923,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342603,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":107.075,"value":171320.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.7900 to $107.5700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1593103,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342602,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1185,"price":105.8011,"value":125374.3035,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.5800 to $106.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1594703,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342601,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":3700,"price":104.4404,"value":386429.48,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.0500 to $104.9100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1595888,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342600,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":84220,"price":103.4899,"value":8715919.378,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.0500 to $104.0300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1599588,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342599,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":55003,"price":102.5867,"value":5642576.2601,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $102.0500 to $103.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1683808,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1342598,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-04T22:44:18.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":24077,"price":101.622,"value":2446752.894,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.0500 to $102.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1738811,"source":{"system":"sec-edgar","filing":"0001736297-24-000061","document":"wk-form4_1733352250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000061/wk-form4_1733352250.xml","form_type":"4"}},{"id":1356986,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-20T22:29:13.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":7398,"price":90.8129,"value":671833.8342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.7000 to $91.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":286424,"source":{"system":"sec-edgar","filing":"0001736297-24-000052","document":"wk-form4_1732141745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000052/wk-form4_1732141745.xml","form_type":"4"}},{"id":1361453,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-18T21:38:47.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":694,"price":30.6,"value":21236.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":293822,"source":{"system":"sec-edgar","filing":"0001736297-24-000049","document":"wk-form4_1731965920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000049/wk-form4_1731965920.xml","form_type":"4"}},{"id":1387477,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-11T20:11:08.000Z","date":"2024-10-09","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":62.0336,"value":6203360.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.0000 to $62.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1762888,"source":{"system":"sec-edgar","filing":"0001736297-24-000036","document":"wk-form4_1728677459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000036/wk-form4_1728677459.xml","form_type":"4"}},{"id":1390660,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:03:11.000Z","date":"2024-10-02","kind":"gift","planned":false,"acquired":true,"shares":1033780,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2024, the Reporting Person transferred 1,033,780 shares of Common Stock to Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\") for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by the Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1862888,"source":{"system":"sec-edgar","filing":"0001736297-24-000035","document":"wk-form4_1728072185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000035/wk-form4_1728072185.xml","form_type":"4"}},{"id":1390659,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:03:11.000Z","date":"2024-10-02","kind":"gift","planned":false,"acquired":false,"shares":1033780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2024, the Reporting Person transferred 1,033,780 shares of Common Stock to Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\") for no consideration."}],"balance_after":293128,"source":{"system":"sec-edgar","filing":"0001736297-24-000035","document":"wk-form4_1728072185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000035/wk-form4_1728072185.xml","form_type":"4"}},{"id":1417491,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":801,"price":49.61,"value":39737.61,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.43 to $49.87. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":829108,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1417490,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":9967,"price":48.74,"value":485791.58,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.37 to $49.29. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":829909,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1417489,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":32628,"price":48,"value":1566144.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.36 to $48.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":839876,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1417488,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":5204,"price":46.95,"value":244327.8,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.36 to $47.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":872504,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1417487,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":700,"price":46.03,"value":32221.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.28 to $46.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":877708,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1417486,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-03T21:22:26.000Z","date":"2024-08-29","kind":"sale","planned":false,"acquired":false,"shares":700,"price":44.26,"value":30982.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.94 to $44.74. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":878408,"source":{"system":"sec-edgar","filing":"0001736297-24-000028","document":"wk-form4_1725398539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000028/wk-form4_1725398539.xml","form_type":"4"}},{"id":1427400,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:03:16.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":13915,"price":41.79,"value":581507.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sale is mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.78 to $41.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1326908,"source":{"system":"sec-edgar","filing":"0001736297-24-000023","document":"wk-form4_1724184190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000023/wk-form4_1724184190.xml","form_type":"4"}},{"id":1432283,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-15T20:20:27.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":74976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent an award of restricted stock units (\"RSUs\") granted on August 13, 2024 (the \"Grant Date\") under the Astera Labs, Inc. Amended and Restated 2024 Stock Option and Incentive Plan. Such award which provides that the RSUs shall vest as to 25% on August 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1340823,"source":{"system":"sec-edgar","filing":"0001736297-24-000021","document":"wk-form4_1723753220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000173629724000021/wk-form4_1723753220.xml","form_type":"4"}},{"id":1508641,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-20T21:42:28.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":4125,"price":76.4,"value":315150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sale is mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.33 to $76.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1265847,"source":{"system":"sec-edgar","filing":"0001399546-24-000006","document":"wk-form4_1716241338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954624000006/wk-form4_1716241338.xml","form_type":"4"}},{"id":1508640,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-20T21:42:28.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":1408,"price":77.48,"value":109091.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sale is mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\", and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.05 to $77.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1269972,"source":{"system":"sec-edgar","filing":"0001399546-24-000006","document":"wk-form4_1716241338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000139954624000006/wk-form4_1716241338.xml","form_type":"4"}},{"id":1563102,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Preferred","published_at":"2024-03-22T20:41:43.000Z","date":"2024-03-22","kind":"exercise","planned":false,"acquired":false,"shares":879108,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":879108},"source":{"system":"sec-edgar","filing":"0000950170-24-035418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000095017024035418/ownership.xml","form_type":"4"}},{"id":1563101,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-22T20:41:43.000Z","date":"2024-03-22","kind":"exercise","planned":false,"acquired":true,"shares":879108,"ownership":{"direct":false,"nature":"By Tate Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the \"Tate Trust\"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":2150488,"source":{"system":"sec-edgar","filing":"0000950170-24-035418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000095017024035418/ownership.xml","form_type":"4"}},{"id":1563100,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-22T20:41:43.000Z","date":"2024-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":28689,"price":36,"value":1032804.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. Such withholding is mandated by an election of the Issuer made in advance and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1271380,"source":{"system":"sec-edgar","filing":"0000950170-24-035418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000095017024035418/ownership.xml","form_type":"4"}},{"id":1564608,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-21T20:27:22.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares represent an award of RSUs granted on February 7, 2024 under the 2018 Plan. Such award vests upon satisfaction of both (i) a time-based condition, which provides that 100% of the RSUs shall vest on February 15, 2025 and (ii) a performance-based condition, which is satisfied upon the occurrence of a change in control of the Issuer or the consummation of an initial public offering of the Issuer's equity securities, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date."}],"balance_after":1300069,"source":{"system":"sec-edgar","filing":"0000950170-24-034747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000095017024034747/ownership.xml","form_type":"4"}},{"id":1564607,"issuer":{"id":1853,"kind":"organization","name":"Astera Labs, Inc.","symbol":"ALAB"},"owners":[{"id":65628,"kind":"person","name":"Tate Michael Truett","position":1,"cik":"0001399546","reported_name":"Tate Michael Truett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-21T20:27:22.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent an award of restricted stock units (\"RSUs\") granted on January 24, 2024 under the Astera Labs, Inc. Amended and Restated 2018 Equity Incentive Plan (\"2018 Plan\"). Such award vests upon satisfaction of both (i) a time-based condition, which provides that the RSUs shall vest as to 25% on February 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, and (ii) a performance-based condition, which is satisfied upon the occurrence of a change in control of the Issuer or the consummation of an initial public offering of the Issuer's equity securities, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":1262569,"source":{"system":"sec-edgar","filing":"0000950170-24-034747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1399546/000095017024034747/ownership.xml","form_type":"4"}}]}